Treatment of kaposi's sarcoma with vinblastine
Open Access
- 1 February 1980
- Vol. 45 (3) , 427-431
- https://doi.org/10.1002/1097-0142(19800201)45:3<427::aid-cncr2820450304>3.0.co;2-1
Abstract
Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.This publication has 14 references indexed in Scilit:
- Epidemiologic aspects of american kaposi's sarcomaJournal of Surgical Oncology, 1979
- Treatment of Cutaneous Kaposi's Sarcoma With Intralesional VincristineArchives of Dermatology, 1978
- Kaposi's sarcoma in renal allograft recipientsCancer, 1978
- Radiotherapy of Kaposi's sarcomaCancer, 1978
- Scintigraphic Evaluation of Kaposi’s SarcomaDermatology, 1978
- Prognosis in Kaposi's Sarcoma 2JNCI Journal of the National Cancer Institute, 1975
- Kaposi Sarcoma, With Emphasis on the Internal ManifestationsArchives of Dermatology, 1974
- Treatment of kaposi's sarcoma with a combination of actinomycin D and vincristineCancer, 1973
- Kaposi's sarcoma.Management with vincaleucoblastineCancer, 1966
- CONCOMITANT OCCURRENCE OF KAPOSI'S SARCOMA AND LYMPHOBLASTOMAArchives of Dermatology, 1954